Men's Health Week in Iran; the Discrepancy between Experts and the General Population for Educational Priorities
Men's Health Journal,
Vol. 4 No. 1 (2020),
19 Farvardin 2020
,
Page e24
https://doi.org/10.22037/mhj.v4i1.33141
Abstract
Introduction: With the obsoletion of the paternalistic model of the doctor-patient relationship, considering public opinion regarding healthcare policymaking seems to be of great necessity. The present study was conducted to determine the educational priorities of male urology specialists and the general male population concerning urological diseases.
Materials and methods: In this cross-sectional survey study, 400 male urologists and 400 men from the general population were assessed. Our investigation was carried out using a seven-item questionnaire covering the most important urological conditions. Respondents gathered from all over Iran through the 22nd Congress of Iranian Urological Association (IUA) and street surveys. Results: The mean age of the participants was 40.69 ± 13.23. The mean age for the general population and urologists was 35.8 ± 13.7 and 45.6 ± 10.6 years, respectively (P=0.0001). 56.8% of the respondents from the general population had a university degree. Overall, erectile dysfunction and sexually transmitted diseases (STDs) were the most mentioned diseases as an educational priority (40.1%). Chronic prostatitis was also the least mentioned condition as an educational priority in both groups and overall among all the participants (20.9%). A significant difference was observed between the general population and urologists in all the examined conditions (P<0.05). Conclusion: This study indicated the differences among the educational priorities of the general male population and male urologists, and the necessity to make these two points of view closer and to involve the opinion of general population in decision making for men’s health week educational topics.
How to Cite
Allameh, F., Hosseini, J., Vakily, S. A., & Jalalinejad, M. (2020). Men’s Health Week in Iran; the Discrepancy between Experts and the General Population for Educational Priorities. Men’s Health Journal, 4(1), e24. https://doi.org/10.22037/mhj.v4i1.33141
References
1. Benbassat J, Pilpel D, Tidhar M. Patients' preferences for participation in clinical decision making: a review of published surveys. Behavioral medicine. 1998;24(2):81-8.
2. Kassirer JP. Incorporating patients' preferences into medical decisions. Mass Medical Soc; 1994.
3. Defechereux T, Paolucci F, Mirelman A, Youngkong S, Botten G, Hagen TP, et al. Health care priority setting in Norway a multicriteria decision analysis. BMC health services research. 2012;12(1):39.
4. Winkelhage J, Diederich A. The relevance of personal characteristics in allocating health care resources—controversial preferences of laypersons with different educational backgrounds. International journal of environmental research and public health. 2012;9(1):223-43.
5. Farmakas A, Theodorou M, Galanis P, Karayiannis G, Ghobrial S, Polyzos N, et al. Public engagement in setting healthcare priorities: a ranking exercise in Cyprus. Cost Effectiveness and Resource Allocation. 2017;15(1):16.
6. Amalraj S, Starkweather C, Naeim A. Health literacy, communication, and treatment decision-making in older cancer patients. Ethics. 2009;23(4).
7. Pruthi A, Nielsen ME, Raynor MC, Woods ME, Wallen EM, Smith AB. Readability of American online patient education materials in urologic oncology: a need for simple communication. Urology. 2015;85(2):351-6.
8. Chen EC, Manecksha RP, Abouassaly R, Bolton DM, Reich O, Lawrentschuk N. A multilingual evaluation of current health information on the Internet for the treatments of benign prostatic hyperplasia. Prostate International. 2014;2(4):161-8.
9. Basiri A, Mousavi S, Naghavi M, Araghi I, Namini S. Urologic diseases in the Islamic Republic of Iran: what are the public health priorities? Eastern Mediterranean health journal. 2008;14(6):1338-48.
10. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, et al. Urologic diseases in America Project: analytical methods and principal findings. The Journal of urology. 2005;173(3):933-7.
11. Miller DC, Saigal CS, Litwin MS. The demographic burden of urologic diseases in America. Urologic Clinics of North America. 2009;36(1):11-27.
12. Solvang M, Elnegaard S, Jarbøl DE. Urological symptoms among 23,240 men in the general danish population–concerns about symptoms, their persistence and influence on primary care contacts. Scandinavian journal of primary health care. 2018;36(3):227-36.
13. Gagnon L-O, Simard A, Tu L-M. Knowledge about urology in the general population: alarming results. Canadian Urological Association Journal. 2009;3(5):388.
14. Scales CD, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, et al. Changing gender prevalence of stone disease. The Journal of urology. 2007;177(3):979-82.
15. Yoshida O, Terai A, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney international. 1999;56(5):1899-904.
16. Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. The Journal of urology. 2004;172(1):159-63.
17. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. Jama. 2005;293(4):455-62.
18. Fenton K, Lowndes C. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sexually transmitted infections. 2004;80(4):255-63.
19. Robinson A, Rafuse J. " Second sexual revolution" creating STD crisis in Canada, doctor warns. CMAJ: Canadian Medical Association Journal. 1993;149(5):691.
20. Aral SO, Fenton KA, Holmes KK. Sexually transmitted diseases in the USA: temporal trends. Sexually transmitted infections. 2007;83(4):257-66.
21. Rahimzadeh S, Naderimagham S, Rohani-Rasaf M, Mehdipour P, Lotfizadeh Dehkordi M, Niakan Kalhori S, et al. Burden of sexually transmitted infections in Iran from 1990 to 2010: Results from the global burden of disease study 2010. Archives of Iranian medicine. 2016;19(11):768-73.
22. Ministry of Health and Medical Education. sexually transmitted infections. Iranian National Center for Addiction Studies (INCAS). report; 2014.
23. Brecher J. Sex, stress, and health. International Journal of Health Services. 1977;7(1):89-101.
24. Raeissadat SA, Javadi A, Allameh F. Enhanced external counterpulsation in rehabilitation of erectile dysfunction: a narrative literature review. Vascular Health and Risk Management. 2018;14:393.
25. Ansong KS, Lewis C, Jenkins P, Bell J. Help-seeking decisions among men with impotence. Urology. 1998;52(5):834-7.
26. Harkaway RC. What are the views of patients and urologists on benign prostatic hyperplasia and its management? european urology supplements. 2007;6(6):454-9.
27. Choo MS, Ku JH, Park CH, Lee YS, Lee KS, Lee JG, et al. Prevalence of nocturia in a Korean population aged 40 to 89 years. Neurourology and Urodynamics: Official Journal of the International Continence Society. 2008;27(1):60-4.
28. Hassanipour-Azgomi S, Mohammadian-Hafshejani A, Ghoncheh M, Towhidi F, Jamehshorani S, Salehiniya H. Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide. Prostate international. 2016;4(3):118-24.
29. Allameh F, Qashqai H, Salavati A. A dynamic model for predicting prostate cancer in Iranian men based on a perceptron neural network. International Journal of Cancer Management. 2017;10(3).
30. Hassanipour S, Fathalipour M, Salehiniya H. The incidence of prostate cancer in Iran: a systematic review and meta-analysis. Prostate international. 2018;6(2):41-5.
31. Pishgar F, Amini E, Gohari K, Aminorroaya A, Sheidaei A, Rostamabadi Y, et al. National and subnational mortality of urological cancers in Iran, 1990–2015. Asia‐Pacific Journal of Clinical Oncology. 2019;15(2):e43-e8.
32. Abasi B, Farahaninia M, Hasanpoor SB, Haghani H. Health Literacy and Men's Attitudes and Practices toward Prostate Cancer Screening. Journal of Client-Centered Nursing Care. 2019;5(2):3-.
33. Khosravi V, Barati M, Moeini B, Mohammadi Y. Prostate cancer screening behaviors and the related beliefs among 50-to 70-year-old men in Hamadan: Appraisal of threats and coping. J Educ Community Health. 2018;4(4):20-31.
34. Rezaeian M, Tabatabaei Z, Naeimi R, Esmaeili A, Jamali M, VaziriNejad R, et al. Knowledge, attitude and practice of Rafsanjan male pensioners towards prevention of prostate cancer in the year 2006. The Horizon of Medical Sciences. 2007;12(4):19-25.
35. Ghodsbin F, Zare M, Jahanbin I, Ariafar A, Keshavarzi S. A survey of the knowledge and beliefs of retired men about prostate cancer screening based on health belief model. International journal of community based nursing and midwifery. 2014;2(4):279.
36. Jeihooni AK, Kashfi SM, Hatami M, Avand A, Bazrafshan M-R. The effect of educational program based on PRECEDE model in promoting prostate cancer screening in a sample of Iranian men. Journal of Cancer Education. 2019;34(1):161-72.
37. Parsanezhad M, Jahromi B, Zare N, Keramati P, Khalili A, Parsa-Nezhad M. Epidemiology and etiology of infertility in Iran, systematic review and meta-analysis. J Womens Health, Issues Care. 2013;2(6):2.
38. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Azizi F. The Prevalence and Causes of Primary Infertility in Iran: A Population-Based Study. Glob J Health Sci. 2015;7(6):226-32.
39. Danial Z, Motamedi M, Mirhashemi S, Kazemi A, Mirhashemi AH. Ageing in iran. Lancet. 2014;384(9958):1927.
40. Aloosh M, Saghai Y. Birth control policies in Iran: a public health and ethics perspective. J Epidemiol Community Health. 2016;70(6):529-33.
41. Nickel JC, Nigro M, Valiquette L, Anderson P, Patrick A, Mahoney J, et al. Diagnosis and treatment of prostatitis in Canada. Urology. 1998;52(5):797-802.
42. Liu LF, Yang JR, Ginsberg DA, Xie HW, Rao JM, Wang L, et al. Factors influencing the diagnosis and treatment of chronic prostatitis among urologists in China. Asian journal of andrology. 2008;10(4):675-81.
43. Allameh F, Tehrani MMM, Tasharrofi MA, Jameshouran MAG. Validation of the Persian Version of the National Institute of Health Chronic Prostatitis Symptom Index. Urology Journal. 2020.
44. Ku JH, Kim SW, PAICK JS. Epidemiologic risk factors for chronic prostatitis. International Journal of andrology. 2005;28(6):317-27.
2. Kassirer JP. Incorporating patients' preferences into medical decisions. Mass Medical Soc; 1994.
3. Defechereux T, Paolucci F, Mirelman A, Youngkong S, Botten G, Hagen TP, et al. Health care priority setting in Norway a multicriteria decision analysis. BMC health services research. 2012;12(1):39.
4. Winkelhage J, Diederich A. The relevance of personal characteristics in allocating health care resources—controversial preferences of laypersons with different educational backgrounds. International journal of environmental research and public health. 2012;9(1):223-43.
5. Farmakas A, Theodorou M, Galanis P, Karayiannis G, Ghobrial S, Polyzos N, et al. Public engagement in setting healthcare priorities: a ranking exercise in Cyprus. Cost Effectiveness and Resource Allocation. 2017;15(1):16.
6. Amalraj S, Starkweather C, Naeim A. Health literacy, communication, and treatment decision-making in older cancer patients. Ethics. 2009;23(4).
7. Pruthi A, Nielsen ME, Raynor MC, Woods ME, Wallen EM, Smith AB. Readability of American online patient education materials in urologic oncology: a need for simple communication. Urology. 2015;85(2):351-6.
8. Chen EC, Manecksha RP, Abouassaly R, Bolton DM, Reich O, Lawrentschuk N. A multilingual evaluation of current health information on the Internet for the treatments of benign prostatic hyperplasia. Prostate International. 2014;2(4):161-8.
9. Basiri A, Mousavi S, Naghavi M, Araghi I, Namini S. Urologic diseases in the Islamic Republic of Iran: what are the public health priorities? Eastern Mediterranean health journal. 2008;14(6):1338-48.
10. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, et al. Urologic diseases in America Project: analytical methods and principal findings. The Journal of urology. 2005;173(3):933-7.
11. Miller DC, Saigal CS, Litwin MS. The demographic burden of urologic diseases in America. Urologic Clinics of North America. 2009;36(1):11-27.
12. Solvang M, Elnegaard S, Jarbøl DE. Urological symptoms among 23,240 men in the general danish population–concerns about symptoms, their persistence and influence on primary care contacts. Scandinavian journal of primary health care. 2018;36(3):227-36.
13. Gagnon L-O, Simard A, Tu L-M. Knowledge about urology in the general population: alarming results. Canadian Urological Association Journal. 2009;3(5):388.
14. Scales CD, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, et al. Changing gender prevalence of stone disease. The Journal of urology. 2007;177(3):979-82.
15. Yoshida O, Terai A, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney international. 1999;56(5):1899-904.
16. Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. The Journal of urology. 2004;172(1):159-63.
17. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. Jama. 2005;293(4):455-62.
18. Fenton K, Lowndes C. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sexually transmitted infections. 2004;80(4):255-63.
19. Robinson A, Rafuse J. " Second sexual revolution" creating STD crisis in Canada, doctor warns. CMAJ: Canadian Medical Association Journal. 1993;149(5):691.
20. Aral SO, Fenton KA, Holmes KK. Sexually transmitted diseases in the USA: temporal trends. Sexually transmitted infections. 2007;83(4):257-66.
21. Rahimzadeh S, Naderimagham S, Rohani-Rasaf M, Mehdipour P, Lotfizadeh Dehkordi M, Niakan Kalhori S, et al. Burden of sexually transmitted infections in Iran from 1990 to 2010: Results from the global burden of disease study 2010. Archives of Iranian medicine. 2016;19(11):768-73.
22. Ministry of Health and Medical Education. sexually transmitted infections. Iranian National Center for Addiction Studies (INCAS). report; 2014.
23. Brecher J. Sex, stress, and health. International Journal of Health Services. 1977;7(1):89-101.
24. Raeissadat SA, Javadi A, Allameh F. Enhanced external counterpulsation in rehabilitation of erectile dysfunction: a narrative literature review. Vascular Health and Risk Management. 2018;14:393.
25. Ansong KS, Lewis C, Jenkins P, Bell J. Help-seeking decisions among men with impotence. Urology. 1998;52(5):834-7.
26. Harkaway RC. What are the views of patients and urologists on benign prostatic hyperplasia and its management? european urology supplements. 2007;6(6):454-9.
27. Choo MS, Ku JH, Park CH, Lee YS, Lee KS, Lee JG, et al. Prevalence of nocturia in a Korean population aged 40 to 89 years. Neurourology and Urodynamics: Official Journal of the International Continence Society. 2008;27(1):60-4.
28. Hassanipour-Azgomi S, Mohammadian-Hafshejani A, Ghoncheh M, Towhidi F, Jamehshorani S, Salehiniya H. Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide. Prostate international. 2016;4(3):118-24.
29. Allameh F, Qashqai H, Salavati A. A dynamic model for predicting prostate cancer in Iranian men based on a perceptron neural network. International Journal of Cancer Management. 2017;10(3).
30. Hassanipour S, Fathalipour M, Salehiniya H. The incidence of prostate cancer in Iran: a systematic review and meta-analysis. Prostate international. 2018;6(2):41-5.
31. Pishgar F, Amini E, Gohari K, Aminorroaya A, Sheidaei A, Rostamabadi Y, et al. National and subnational mortality of urological cancers in Iran, 1990–2015. Asia‐Pacific Journal of Clinical Oncology. 2019;15(2):e43-e8.
32. Abasi B, Farahaninia M, Hasanpoor SB, Haghani H. Health Literacy and Men's Attitudes and Practices toward Prostate Cancer Screening. Journal of Client-Centered Nursing Care. 2019;5(2):3-.
33. Khosravi V, Barati M, Moeini B, Mohammadi Y. Prostate cancer screening behaviors and the related beliefs among 50-to 70-year-old men in Hamadan: Appraisal of threats and coping. J Educ Community Health. 2018;4(4):20-31.
34. Rezaeian M, Tabatabaei Z, Naeimi R, Esmaeili A, Jamali M, VaziriNejad R, et al. Knowledge, attitude and practice of Rafsanjan male pensioners towards prevention of prostate cancer in the year 2006. The Horizon of Medical Sciences. 2007;12(4):19-25.
35. Ghodsbin F, Zare M, Jahanbin I, Ariafar A, Keshavarzi S. A survey of the knowledge and beliefs of retired men about prostate cancer screening based on health belief model. International journal of community based nursing and midwifery. 2014;2(4):279.
36. Jeihooni AK, Kashfi SM, Hatami M, Avand A, Bazrafshan M-R. The effect of educational program based on PRECEDE model in promoting prostate cancer screening in a sample of Iranian men. Journal of Cancer Education. 2019;34(1):161-72.
37. Parsanezhad M, Jahromi B, Zare N, Keramati P, Khalili A, Parsa-Nezhad M. Epidemiology and etiology of infertility in Iran, systematic review and meta-analysis. J Womens Health, Issues Care. 2013;2(6):2.
38. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Azizi F. The Prevalence and Causes of Primary Infertility in Iran: A Population-Based Study. Glob J Health Sci. 2015;7(6):226-32.
39. Danial Z, Motamedi M, Mirhashemi S, Kazemi A, Mirhashemi AH. Ageing in iran. Lancet. 2014;384(9958):1927.
40. Aloosh M, Saghai Y. Birth control policies in Iran: a public health and ethics perspective. J Epidemiol Community Health. 2016;70(6):529-33.
41. Nickel JC, Nigro M, Valiquette L, Anderson P, Patrick A, Mahoney J, et al. Diagnosis and treatment of prostatitis in Canada. Urology. 1998;52(5):797-802.
42. Liu LF, Yang JR, Ginsberg DA, Xie HW, Rao JM, Wang L, et al. Factors influencing the diagnosis and treatment of chronic prostatitis among urologists in China. Asian journal of andrology. 2008;10(4):675-81.
43. Allameh F, Tehrani MMM, Tasharrofi MA, Jameshouran MAG. Validation of the Persian Version of the National Institute of Health Chronic Prostatitis Symptom Index. Urology Journal. 2020.
44. Ku JH, Kim SW, PAICK JS. Epidemiologic risk factors for chronic prostatitis. International Journal of andrology. 2005;28(6):317-27.
- Abstract Viewed: 203 times
- pdf Downloaded: 99 times